A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
Key Details
- 1Researchers developed a deep learning model (SurvFinder) trained on whole slide histopathology images from stage II colorectal cancer patients.
- 2The study retrospectively analyzed multi-center data from patients in China and the United States.
- 3The AI model identified features associated with risk of recurrence at a higher success rate than traditional clinical prognostic tools.
- 4Study details and results are published in PLOS Medicine, open access.
Why It Matters
Digital pathology AI models can enhance prognostic accuracy and help personalize treatment plans for cancer patients. Outperforming current clinical tools could enable better risk stratification and improved outcomes in stage II colorectal cancer.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
AI Deep Learning Model Enhances Echocardiogram RV Assessment and Prognosis
Researchers developed DROID-RV, a deep learning tool that automates right ventricular assessment from echocardiograms, showing strong prognostic links with cardiovascular outcomes.